IRIS
VITALE, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.545
EU - Europa 7.897
AS - Asia 4.669
SA - Sud America 842
Continente sconosciuto - Info sul continente non disponibili 332
AF - Africa 99
OC - Oceania 16
Totale 31.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.388
RU - Federazione Russa 2.458
CN - Cina 1.803
UA - Ucraina 1.531
SG - Singapore 1.209
VN - Vietnam 1.094
IT - Italia 839
GB - Regno Unito 758
SE - Svezia 674
BR - Brasile 657
DE - Germania 643
FR - Francia 523
FI - Finlandia 150
HK - Hong Kong 135
NL - Olanda 84
BD - Bangladesh 74
AR - Argentina 63
IN - India 59
CA - Canada 57
PL - Polonia 52
MX - Messico 46
JP - Giappone 44
IQ - Iraq 42
EU - Europa 39
ZA - Sudafrica 31
EC - Ecuador 30
IE - Irlanda 30
ID - Indonesia 25
PK - Pakistan 24
BE - Belgio 22
ES - Italia 22
SA - Arabia Saudita 19
AT - Austria 18
CL - Cile 18
MA - Marocco 18
MY - Malesia 18
TR - Turchia 18
VE - Venezuela 18
CO - Colombia 17
PY - Paraguay 16
LV - Lettonia 15
AU - Australia 12
AZ - Azerbaigian 12
CR - Costa Rica 12
TN - Tunisia 12
UZ - Uzbekistan 11
JM - Giamaica 10
KE - Kenya 10
BO - Bolivia 8
UY - Uruguay 8
BG - Bulgaria 7
ET - Etiopia 7
GR - Grecia 7
HN - Honduras 7
JO - Giordania 7
KR - Corea 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
KZ - Kazakistan 6
LU - Lussemburgo 6
NP - Nepal 6
PH - Filippine 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
DK - Danimarca 5
GT - Guatemala 5
IR - Iran 5
LB - Libano 5
PA - Panama 5
PE - Perù 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
BH - Bahrain 4
EG - Egitto 4
LT - Lituania 4
NI - Nicaragua 4
OM - Oman 4
HR - Croazia 3
IL - Israele 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
Totale 31.078
Salva come PNG Salva come JPEG
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.681
Ann Arbor 1.318
Ashburn 1.137
Dallas 1.107
Wilmington 1.056
Chandler 897
Seattle 842
Dong Ket 774
Cambridge 694
San Jose 561
Dearborn 535
Singapore 453
Nyköping 441
Jacksonville 429
Shenzhen 397
Southend 392
Moscow 381
Beijing 337
Boardman 286
Lawrence 152
Princeton 152
Hong Kong 127
The Dalles 127
Ho Chi Minh City 114
Ogden 108
Shanghai 108
New York 105
Naples 103
Santa Clara 84
Hanoi 75
Los Angeles 75
San Diego 74
Grafing 69
Norwalk 63
Düsseldorf 62
Rome 57
London 54
Des Moines 52
Groningen 49
Chicago 47
São Paulo 45
Yubileyny 44
Munich 43
Milan 40
Falls Church 39
Nanjing 36
Kraków 34
Jinan 31
Columbus 30
Dublin 29
Tokyo 27
Rio de Janeiro 25
Bergamo 22
Shenyang 22
Helsinki 21
Hefei 19
Nanchang 19
Napoli 19
Amsterdam 18
Brussels 18
Frankfurt am Main 18
Toledo 18
Edinburgh 17
Mexico City 17
Council Bluffs 16
Auburn Hills 15
Baghdad 15
Guayaquil 15
Montreal 15
Phoenix 15
Redwood City 15
Riga 15
Warsaw 15
Boston 14
Brasília 14
Bremen 14
Haiphong 14
Kunming 14
Washington 14
Belo Horizonte 13
Changsha 13
Curitiba 13
Da Nang 13
Salt Lake City 13
Kilburn 12
Miami 12
Toronto 12
Vienna 12
Baku 11
Florence 11
Guangzhou 11
Johannesburg 11
Lahore 11
Orem 11
Stockholm 11
Atlanta 10
Catania 10
Hangzhou 10
Totale 20.655
Salva come PNG Salva come JPEG
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 657
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 338
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 323
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 321
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 315
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 297
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 288
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 287
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 282
Abnormal eating behaviors in progressive supranuclear palsy 282
Cognitive and affective theory of mind in patients with essential tremor 279
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 270
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 266
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 260
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 257
Affective theory of mind in patients with Parkinson's disease: comment 254
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 254
Impact of cognitive tasks on kinematic gait parameters in FTD patients 253
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 253
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 252
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 252
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 252
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 251
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 248
Apoptotic mechanisms in mutant LRRK2-mediated cell death 244
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 242
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 242
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 240
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 238
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 237
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 235
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 235
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 231
Pathological gambling in Parkinson's disease. A comprehensive review 230
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 229
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 227
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 225
The "eye of the tiger" sign in pure akinesia with gait freezing 223
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 222
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 222
Gender and non motor fluctuations in Parkinson's disease: A prospective study 221
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 220
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 220
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 220
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 220
Gender and non motor fluctuations in Parkinson's disease: a prospective study 219
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 218
How does smoking affect olfaction in Parkinson's disease? 217
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 216
Electrophysiological comparison between males and females in HNPP 214
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 213
Season of birth and Parkinson's disease: possible relationship? 211
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 210
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 210
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 209
A (single case) rehabilitation program based on cueing for freezing of speech 209
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 209
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 208
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 207
Normative data for the Montreal Cognitive Assessment in an Italian population sample 207
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 207
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 206
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 205
Early MRI findings in Acquired hepatocerebral degeneration 204
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 202
Uric acid relates to dopamine transporter availability in Parkinson's disease 202
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 202
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 200
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 200
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 200
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 199
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 199
The closing-in phenomenon in Parkinson's disease 198
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 198
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 198
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 197
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 196
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 196
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 193
Linkage exclusion in Italian families with hereditary essential tremor 192
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 192
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 191
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 191
The relationship between cerebral vascular disease and parkinsonism: the VADO study 191
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 189
Hemi-Restless Legs Syndrome induced by Clebopride 188
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 188
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 186
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 184
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 183
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 183
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 182
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 182
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 181
Using gait analysis' parameters to classify Parkinsonism: A data mining approach 181
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease 181
Reply to Zappia et al.'s comment on personality and Parkinson's Disease: A meta-analysis 179
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 177
Quitting smoking: an early non-motor feature of Parkinson's disease? 177
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 176
Totale 22.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.339 0 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20254.479 61 360 26 109 96 401 1.121 1.358 336 238 206 167
2025/20265.459 377 863 793 480 224 112 540 524 623 577 186 160
2026/2027336 112 224 0 0 0 0 0 0 0 0 0 0
Totale 31.400